A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma-Reference-Cited by-同舟云学术

A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma

Published:2013-02-22 Issue:3 Volume:46 Page:141-152
ISSN:1860-1480
Container-title:Medical Molecular Morphology
language:en
Short-container-title:Med Mol Morphol

Author:

Fujii Masato,Shibazaki Yuichiro,Wakamatsu Kyoko,Honda Yutaka,Kawauchi Yusuke,Suzuki Kenji,Arumugam Somasundaram,Watanabe Kenichi,Ichida Takafumi,Asakura Hitoshi,Yoneyama Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00795-013-0016-1.pdf

Reference41 articles.

1. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD (2009) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 3:353–367

2. Trevisani F, Cantarini MC, Wands JR, Bernardi M (2008) Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 29:1299–1305

3. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51:1972–1978

4. Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206–S214

5. Blonski W, Kotlyar DS, Forde KA (2010) Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 16:3603–3615

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

2. DDX5 deficiency drives non-canonical NF-κB activation and NRF2 expression, influencing sorafenib response and hepatocellular carcinoma progression;Cell Death & Disease;2024-08-09

3. PPARγ regulates PNPLA3 in adipocytes in vitro and in vivo in healthy obese patients and mice with metabolic dysfunction-associated steatohepatitis;2024-08-09

4. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease;Frontiers in Immunology;2024-08-02

5. A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma;Nature Communications;2024-08-02